MIR572 and renal cell carcinoma: Previous studies have found MIR572 is upregulated in several types of cancer/malignancy such as non-small cell lung cancer [38], ovarian cancer [39], renal cell carcinoma [40], contributing to malignant development, poor prognosis, and shortened survival time.